News
Academy
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in Medicine
Conference CoverageConference Listing
Pharmaceutical Executive
Partner Perspectives
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers
Subscribe
Corporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate Communications
Direct-to-ConsumerDirect-to-ConsumerDirect-to-ConsumerDirect-to-Consumer
Emerging BiopharmaEmerging BiopharmaEmerging Biopharma
IR Licensing and PartnershipsIR Licensing and PartnershipsIR Licensing and Partnerships
Market AccessMarket AccessMarket AccessMarket Access
Medical AffairsMedical AffairsMedical AffairsMedical Affairs
OperationsOperationsOperationsOperationsOperations
Patient EngagementPatient Engagement
RegulatoryRegulatoryRegulatoryRegulatory
Sales & MarketingSales & MarketingSales & MarketingSales & MarketingSales & Marketing
Spotlight -
  • Latest Executive Roundtables
  • Asembia 2025
  • Sales Effectiveness
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

Corporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate Communications
Direct-to-ConsumerDirect-to-ConsumerDirect-to-ConsumerDirect-to-Consumer
Emerging BiopharmaEmerging BiopharmaEmerging Biopharma
IR Licensing and PartnershipsIR Licensing and PartnershipsIR Licensing and Partnerships
Market AccessMarket AccessMarket AccessMarket Access
Medical AffairsMedical AffairsMedical AffairsMedical Affairs
OperationsOperationsOperationsOperationsOperations
Patient EngagementPatient Engagement
RegulatoryRegulatoryRegulatoryRegulatory
Sales & MarketingSales & MarketingSales & MarketingSales & MarketingSales & Marketing
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

    • Academy
    • Partner Perspectives
    • Subscribe
Advertisement

News

Article

February 24, 2025

Popular Flu Vaccine Educational Campaign Ending at CDC

Author(s):

Mike Hollan

Anonymous reports claim the decision came from new leadership at HHS.

Stock.adobe.com

Stock.adobe.com

Unconfirmed reports suggest that a popular flu vaccine educational campaign has come to an end.

NPR reports that it has spoken with two anonymous sources at the CDC who claim that the agency has been advised to end the Wild to Mild campaign.1 According to the sources, paid media for the campaign ended on Wednesday and the campaign’s website was temporarily taken down.

As of Friday morning, the website is up and active. However, the site shows details from the campaign from its initial launch in 2023, as opposed to the updated 2024 which had reportedly been active up until Wednesday.

Campaign imagery would show two different animals, such as a lion and a house cat. The messaging said that getting a flu was like reducing the severity of the illness from a lion to a house cat (or other similar animal comparisons).

According to NPR’s report, leadership at the National Center for Immunization and Respiratory Diseases reviewed the campaign and made the decision not to continue. The report does not a cite a specific reason for the campaign’s conclusion.

The NPR report notes that the decision was made during Robert F. Kennedy Jr.’s first full week as the head of HHS. Kennedy has previously criticized aspects of vaccines and has been described as being anti-vax. However, Kennedy denies being anti-vax. During his confirmation hearings, he stated that he would make decisions based on science and research.

In a statement to NPR, HHS spokesperson Andrew Nixon said, “Unfortunately, officials inside the CDC who are averse to Secretary Kennedy and President Trump's agenda seem to be intentionally falsifying and misrepresenting guidance they receive."

The current Wild to Mild website (dated September, 2023),2 explains, “The Wild to Mild campaign is based on consumer research showing that many people believe flu vaccination doesn't work because of first or second-hand experience where vaccination may not have prevented illness. Flu vaccine varies in how well it works. For many years, CDC measured vaccine effectiveness according to how well it prevented illness that required medical treatment. In recent years, however, CDC has expanded its vaccine effectiveness work to include looking at how well flu vaccine works at preventing serious outcomes, like emergency department visits and hospitalizations. This work has contributed to a strong and growing body of evidence that flu vaccination reduces the risk of serious outcomes in people who get vaccinated but still get sick. The Wild to Mild campaign visually shows how flu vaccination can tame flu illness from wild to mild by showing a wild animal, like a tiger, juxtaposed against a more domesticated animal or toy like a kitten. Other examples include a bear with a teddy bear and a shark with a goldfish.”

Sources

  1. Stone, Will. Trump Administration Yanks CDC Flu Vaccine Campaign. NPR. February 20, 2025. https://www.npr.org/sections/shots-health-news/2025/02/19/nx-s1-5302906/cdc-flu-vaccine-campaign-terminated
  2. New Wild to Mild Campaign Drives Key Message to Tame Flu and Reset Expectations. CDC. September 22, 2023. Accessed February 21, 2025. https://www.cdc.gov/flu/whats-new/2023-2024-new-campaign-wild-to-mild.html

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Related Videos
Ted Sweetser
Ted Sweetser
Ted Sweetser
Amy Hessels, Bayer
Related Content
Advertisement
James Van Der Beek
August 1st 2025

Guardant Partners with James Van Der Beek on Colorectal Cancer Screening Campaign

Mike Hollan
The actor was diagnosed with the disease at 46-years-old.
Jennifer Butler
August 1st 2025

The Misinformation Maze: Navigating Public Health in the Digital Age

Miranda Schmalfuhs
Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
Credit: AspctStyle | stock.adobe.com. Group of pharmacists standing together and looking at the camera in a chemist. Group of healthcare professionals working in a pharmacy.
August 1st 2025

Flawless but Fake? The Ethics of AI Social Media Influencers in Pharmaceutical Advertising

Thani Jambulingam, PhD
AI influencers represent the cutting edge of digital storytelling. But when applied to pharmaceutical marketing, innovation must be balanced with integrity.
Navigating Distrust: Pharma in the Age of Social Media
August 1st 2025

Navigating Distrust: Pharma in the Age of Social Media

Miranda Schmalfuhs
Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
Stock.adobe.com
August 1st 2025

Humana Announces Digital Cognitive Games Event for Older Adults

Mike Hollan
The games are designed to promote activities that exercise the brain.
Study: TV Ads Nearly Match Doctors in Driving Awareness of New Medications Among US Consumers
August 1st 2025

Study: TV Ads Nearly Match Doctors in Driving Awareness of New Medications Among US Consumers

Don Tracy, Associate Editor
Research from a recent Cadent study reveals the growing impact of TV and connected TV advertising in raising medication awareness across diverse demographic groups, highlighting shifting dynamics in how patients discover treatment options.
Related Content
Advertisement
James Van Der Beek
August 1st 2025

Guardant Partners with James Van Der Beek on Colorectal Cancer Screening Campaign

Mike Hollan
The actor was diagnosed with the disease at 46-years-old.
Jennifer Butler
August 1st 2025

The Misinformation Maze: Navigating Public Health in the Digital Age

Miranda Schmalfuhs
Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
Credit: AspctStyle | stock.adobe.com. Group of pharmacists standing together and looking at the camera in a chemist. Group of healthcare professionals working in a pharmacy.
August 1st 2025

Flawless but Fake? The Ethics of AI Social Media Influencers in Pharmaceutical Advertising

Thani Jambulingam, PhD
AI influencers represent the cutting edge of digital storytelling. But when applied to pharmaceutical marketing, innovation must be balanced with integrity.
Navigating Distrust: Pharma in the Age of Social Media
August 1st 2025

Navigating Distrust: Pharma in the Age of Social Media

Miranda Schmalfuhs
Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
Stock.adobe.com
August 1st 2025

Humana Announces Digital Cognitive Games Event for Older Adults

Mike Hollan
The games are designed to promote activities that exercise the brain.
Study: TV Ads Nearly Match Doctors in Driving Awareness of New Medications Among US Consumers
August 1st 2025

Study: TV Ads Nearly Match Doctors in Driving Awareness of New Medications Among US Consumers

Don Tracy, Associate Editor
Research from a recent Cadent study reveals the growing impact of TV and connected TV advertising in raising medication awareness across diverse demographic groups, highlighting shifting dynamics in how patients discover treatment options.
About
Advertise
Contact Us
Editorial Board
Editorial Submission Guidelines
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.